TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Historical Holders from Q4 2021 to Q3 2025

Symbol
TXMD on Nasdaq
CUSIP
88338N206
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
11.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
3.3M
Holdings value
$3.54M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
41
Number of buys
7
Number of sells
-11
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Clearline Capital LP 5.5% $629K 635K Clearline Capital LP Dec 31, 2024

Institutional Holders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 3.3M $3.54M +$51.3K $1.08 41
2025 Q2 3.26M $3.78M -$96.8K $1.16 39
2025 Q1 3.34M $3.09M -$162K $0.93 39
2024 Q4 3.53M $3.03M +$128K $0.86 36
2024 Q3 3.38M $5.61M -$32.7K $1.66 34
2024 Q2 3.41M $5.49M -$143 $1.61 33
2024 Q1 3.38M $7.73M +$287K $2.29 41
2023 Q4 3.25M $7.32M -$53.3K $2.25 34
2023 Q3 2.99M $9.02M -$190K $3.02 37
2023 Q2 3.03M $12.5M -$299K $4.12 39
2023 Q1 3.11M $11.7M -$1.64M $3.75 39
2022 Q4 3.48M $19.4M +$6.04M $5.59 43
2022 Q3 2.07M $13.7M +$169K $6.64 26
2022 Q2 1.72M $17.1M +$17.1M $9.95 31
2022 Q1 10.8K $4.1K +$304 $0.38 2
2021 Q4 10K $3.56K $0 $0.36 1